The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
Additional information provided by Astellas Pharma US, Inc, and Medivation, Inc.
The reprint you are linking to contains data from a company-sponsored multinational, randomized, double-blind, additional trial in metastatic CRPC for XTANDI® (enzalutamide) capsules—a product co-promoted by Medivation, Inc. and Astellas Pharma US, Inc.
This reprint includes information that is not contained in the approved product labeling. Please see Full Prescribing Information for XTANDI.